Health News
Markets, macro and movers — curated.
Earnings Roundup: Diversification, Resilience, and Demand Drive Major Stock Rallies
An analysis of standout quarterly earnings from Qualcomm, Royal Caribbean, and Eli Lilly, highlighting business diversification, consumer resilience, and pharmaceutical demand.
The Great Reclassification: What Moving Marijuana to Schedule III Means for Markets and Policy
An analysis of the federal reclassification of marijuana from Schedule I to Schedule III and its immediate impact on cannabis equities and regulatory policy.
Reading Between the Lines of UnitedHealth's Turnaround Quarter
An analysis of UnitedHealth's latest earnings beat, the medical care ratio surprise, Optum's mixed showing, and the multi-year margin recovery path ahead.
Market Movers and Macro Crosscurrents: Pharma Deals, Psychedelic Breakthroughs, and an Airline Standoff
A market analysis covering Eli Lilly's oncology push, Trump's psychedelic executive order, a rejected airline merger, and key upcoming catalysts.
The GLP-1 War: Eli Lilly vs. Novo Nordisk and the Future of Weight Loss Drugs
An analysis of the GLP-1 drug market, comparing Eli Lilly's and Novo Nordisk's competing products, pricing strategies, and future pipelines.
LNG's Structural Advantage and the Medicare Catalyst for Health Insurers
How the Strait of Hormuz closure creates a multi-year tailwind for US LNG exporters, and why 2027 Medicare rates are reviving health insurers.
Stock Market Opportunities in Times of Geopolitical Uncertainty
How to find quality stock opportunities amid rising oil prices, geopolitical tension, and market volatility by focusing on durable earnings.
Market Rally Continues as Nike Plunges, Eli Lilly Surges, and Microsoft Eyes Major Energy Deal
A look at key market moves including Nike's 11-year low, Eli Lilly's FDA-approved weight loss pill, and Microsoft's $7B energy deal with Chevron.
Why a V-Shaped Market Recovery May Be Imminent — And Where the Smart Money Is Heading
An analysis of the emerging V-shaped market bottom, the case for AI optical networking stocks, and why healthcare remains a compelling play.
AI's Transition From Infrastructure Hype to Real-World Application
AI is moving beyond chips and data centers into practical applications in healthcare, air traffic control, and enterprise — reshaping industries and jobs.
Novo Nordisk's Subscription Model for Wegovy: A New Era in Weight Loss Drug Pricing
Novo Nordisk launches a flat-rate subscription plan for Wegovy to reduce cost uncertainty and improve patient retention on GLP-1 drugs.
Novo Nordisk's Wegovy Subscription Gambit: Fighting Decline with Affordability
Novo Nordisk launches a Wegovy subscription program to combat patient dropout and stabilize its stock after a 75% decline from all-time highs.
Eli Lilly's $2.75 Billion Bet on AI-Powered Drug Discovery
Eli Lilly partners with Insilico Medicine in a deal worth up to $2.75 billion to develop drugs using generative AI tools.
The Landmark Social Media Addiction Verdict That Could Reshape Big Tech
A California jury's landmark verdict against Meta and YouTube for addictive platform design could trigger a seismic shift in social media regulation.
A Landmark Ruling on Social Media Addiction and Its Implications for Big Tech
A jury ruling finding Meta and YouTube liable for youth mental health harm could reshape the legal landscape for social media companies.
Market Movers: Delta Soars While Eli Lilly and DraftKings Face Headwinds
An analysis of key market movers as Delta Airlines raises guidance on strong demand while Eli Lilly and DraftKings face analyst downgrades.
How Autonomous Robots Are Transforming Hospital Operations
Autonomous delivery robots are entering hospitals to handle supply logistics, freeing nurses to focus on patient care.